Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07431320Not ApplicableNot Yet Recruiting

Ecological Test Standardization for Concussion Assessment in Football Players

Role: collaborator

NCT07419087Not ApplicableNot Yet Recruiting

Trunk Impairment Scale - Adaptation and Validation in French

Role: collaborator

NCT07213531Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Role: collaborator

NCT05040464Phase 3Recruiting

Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

Role: collaborator

All 4 trials loaded